Dear Sirs, I recently read the article by Csiszar and colleagues (1). They show for the first time, in fibroblasts from 13 primate species including anthropoids and humans, that the mean level of reactive oxygen species (ROS) is low in long-lived compared with short-lived animals. Their measurements are not "ROS production" because they were performed in whole cells, and thus cellular antioxidants interfere. But the negative correlation between mitochondrial ROS production (mtROSp) and longevity observed in many studies in mammals and birds (2) prevailed even with interference from cellular antioxidants. Long-lived animals have less endogenous antioxidants (3-5) and less mtROSp (2) than short-lived ones. Therefore, in whole cells, both factors would tend to cancel each other, but still the low mtROSp of the long-lived species seems to have predominated in this case.
Dear Sirs, I recently read the article by Csiszar and colleagues (1) . They show for the first time, in fibroblasts from 13 primate species including anthropoids and humans, that the mean level of reactive oxygen species (ROS) is low in long-lived compared with short-lived animals. Their measurements are not "ROS production" because they were performed in whole cells, and thus cellular antioxidants interfere. But the negative correlation between mitochondrial ROS production (mtROSp) and longevity observed in many studies in mammals and birds (2) prevailed even with interference from cellular antioxidants. Long-lived animals have less endogenous antioxidants (3) (4) (5) and less mtROSp (2) than short-lived ones. Therefore, in whole cells, both factors would tend to cancel each other, but still the low mtROSp of the long-lived species seems to have predominated in this case.
I am worried about the appropriateness of correcting by body size in longevity-related comparative studies. Although correcting by body size can be useful in other occasions, at least in the case of the mitochondrial oxygen radical theory of aging, it can be misleading due to the wellknown decrease in weight-specific aerobic metabolic rate as body size increases, which in many (although not in all) species leads to decreases in mtROSp. In 2005, an article was published (6) that stated the need for such correction, as well as correcting for phylogeny. That article was so influential that many studies published after that date have corrected for body size the associations with longevity of physiological parameters possibly relevant for aging. The effect of these corrections varied. In some cases, the correlation persisted even after performing the correction, as in one investigation comparing mtROSp with longevity in 12 mammalian species (7) . But in other cases, like in the 13 primates referred to above (1), the negative correlation disappeared after correcting for body size.
The fundamental reason for claiming the need to correct for body size is the previous description of the existence of a negative association between body size and weight-specific metabolic rate (8, 9) and thus a positive one between body size and longevity. That fundamental finding in comparative physiology occurred various decades earlier (8) than the description of correlations between longevity and the rate of mtROSp or other parameters potentially contributing to aging. However, the date of discovery tells nothing about the biological meaning of the associations. Correcting for body size is a mathematical option, whereas longevity is a biological trait. Statistical methods should help comparative longevity studies instead of obstructing them. They should not erase meaningful biological concepts and functions.
In order for a correlation to be causal, there must be a mechanism connecting the two variables in the correlation. The existence of causality is very likely in the case of the association between mtROSp and longevity because ROS are the only known substances that are normally, endogenously, and rather continuously produced by cells in aerobic tissues, which can break covalent bonds of all kinds of cellular macromolecules including DNA. Therefore, they can promote the progressive accumulation of final forms of irreversible damage relevant for aging, like nonrepairable somatic DNA modifications (2) .
Almost one century after description of the correlation between body size and metabolic rate (8), body size "in itself" still does not have any known or proposed physiological mechanism to cause aging. Later, it was proposed that the intensity of the weight-specific metabolic rate could help to explain the strongly different aging rates of the different mammalian species. High longevity (and high body size) is frequently associated with low weight-specific metabolic rates across species: the "Pearl's rate of living" theory of aging (10) . That theory was dismissed a long time ago as the sole explanation of aging because too many exceptions to it exist. But now it is known that mtROSp is lower in long-lived than in short-lived species both when they "follow" and when they do not "follow" the rate of living theory because the percent free radical leak (%FRL) in the respiratory chain is not a constant (2) . Instead, it can be lower in extraordinarily long-lived species (for their body size and metabolic rate) like flying birds and bats (2,11), or (most likely) in primates including humans (1, 2) , which live between twofold and fourfold longer than expected for their body size and metabolic rate.
What is the reason why body size correlates with longevity? The most likely answer is that many (although not all) mammalian species "follow" the rate of living theory (like those studied in Ref. (12)). The animals with large body size have superior longevity likely in part because their rates of mtROSp are low due to (mechanistically) their low aerobic metabolic rates and thus low rates of mitochondrial O 2 consumption. This occurs in the rat to cow kind of animals that do not showing exceptional longevity for their body size or metabolic rate. Therefore, the positive body size-longevity association in that kind of animals would be due to negative mtROSp-longevity association, not the other way around. Thus, if any correction should be done, that would be correcting the body size-longevity correlation by mtROSp instead of the reverse. In species following the rate of living theory (most mammals), the better the quality of the correlation of mtROSp with longevity (points near the curve), the smaller the residuals, and then the correlation of mtROSp with longevity will be more easily and strongly erased after correcting for body size. Correcting by body size would eliminate associations with longevity in animals that follow the rate of living theory (which are most of the mammalian species), leaving unaffected only species comparisons not following that theory, like comparing birds with lower %FRL than mammals of similar body size.
Correcting mtROSp-longevity, or fatty acid unsaturation-longevity (13) correlations for body size, can "destroy" or "erase" the association between the two parameters entered in the comparison, even if they were indeed causally connected. The original study claiming the need of such correction is an excellent example of how to systematically destroy all the correlations taken by the author from the literature using successive steps of statistical transformations. That destruction also happened in the most interesting primate study (1) , as well as in other investigations published from 2005 onward. Correction by body size can lead to the wrong (in my opinion) conclusion that mtROSp, for instance, would not be causal concerning longevity, a biological conclusion that cannot be deduced from a simple statistical transformation. Correcting by body size in the Csiszar and colleagues (1) study led to dismiss the inescapable fact that the fibroblasts from long-lived primates have smaller "ROS levels" than those obtained from short-lived species, which can be most important for gerontology. A statistical method that leads to lose or disregard relevant biological facts is strongly undesirable and should be avoided. As recently pointed out by others (14) , the notion that longevityrelated comparative studies are invalid unless correction for body size is applied (6) "would eliminate from consideration nearly all cellular properties that lead to delayed aging in mammals, because larger species of mammals are, in general, longer lived than small species" (14) .
It is my opinion that gerontologists should not destroy or erase, themselves, meaningful mechanistic and potentially causal correlations between parameters suspected to cause aging and longevity. Those comparative studies can help to design better lifelong gerontological experiments. They can save large amounts of time and resources helping us to discard parameters that cannot be causally related to longevity because they do not correlate with it, or correlate in the wrong way. A well-known example is that of the endogenous antioxidant enzyme activities and levels of low molecular weight antioxidants in mammals or vertebrates in general, which do correlate with longevity but in the wrong way: Long-lived animals have less endogenous antioxidant levels, instead of more, compared with short-lived ones (3, 4) . This has been recently reconfirmed after reviewing 78 different associations between antioxidants and longevity without correcting by body size (5) . Among the 78 correlations studied, 72 were negative, 6 did not show significant differences, and only a single one was positive (5), corroborating investigations performed two decades ago (reviewed in Ref. (4)). Those negative correlations between antioxidants and longevity, together with the lack of effect of antioxidant dietary supplementation on (maximum) longevity led to predict that increasing antioxidants over normal levels should not produce increases in longevity (3, 4, 15) . This was indeed found when it was tested in transgenic and knockout mouse models (16, 17) . That is not surprising because the trait that seems to be causally involved in the control of animal longevity is not the antioxidant levels but the rate of mtROSp (2) .
Biogerontologists should at least think it twice before deciding to accept claims (6) that correcting for body size is necessary. My answer to the question posed in the title of this commentary is analogous to that of the Prince of Denmark: (please) do not correct.
